Boothbay Fund Management »

Travere Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.0M 166k 23.90

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Travere Therapeutics

Henderson Group
BlackRock
Armistice Capital
Vanguard Group
Macquarie Group
Perceptive Advisors
Adage Capital Partners GP
State Street Corporation
FMR
Rock Springs Capital Management
Emerald Advisers
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Deutsche Bank Aktiengesellschaft

View all funds holding Travere Therapeutics